Joseph Mikhael, MD, has spent decades advancing the treatment of multiple myeloma, and he’s been witness to a remarkable ...

A hematopoietic stem cell transplant (HSCT) can restore the body’s ability to produce healthy blood cells following ...

Lauren Madigan, MD, shares open-label extension results demonstrating sustained improvements with avapritinib in patients ...

Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

Nonsteroidal topicals like roflumilast are enabling proactive, long-term psoriasis control across a broad range of patients, ...

There were few incidences of complications in the follow-up period after the MicroShunt was implanted in the patient.

When TrumpRx launched on February 5, 2026, 1 the Trump administration lauded the move as giving Americans new options to ...

New FDA approvals and emerging trial data drive two pivotal 2026 NCCN guideline updates: lutetium-177 PSMA-617 for ...

New research is shedding light on why many patients with chronic spontaneous urticaria (CSU) remain hesitant to adopt advanced treatments, even as newer biologic and targeted therapies show promise in ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...

Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers. This content was developed independently ...

The study, evaluating the efficacy of the combination of efgartigimod alfa and hyaluronidase-qvfc, is the first to ...